↓ Skip to main content

Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia

Overview of attention for article published in Cancer Epidemiology, Biomarkers & Prevention, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
12 news outlets
twitter
4 tweeters

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
29 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia
Published in
Cancer Epidemiology, Biomarkers & Prevention, December 2018
DOI 10.1158/1055-9965.epi-18-0128
Pubmed ID
Authors

Jie-Bin Lew, D. James B. St John, Finlay A. Macrae, Jon D. Emery, Hooi C. Ee, Mark A. Jenkins, Emily He, Paul Grogan, Michael Caruana, Marjolein J.E. Greuter, Veerle M.H. Coupé, Karen Canfell

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 14%
Other 3 10%
Researcher 3 10%
Student > Bachelor 2 7%
Student > Ph. D. Student 2 7%
Other 4 14%
Unknown 11 38%
Readers by discipline Count As %
Medicine and Dentistry 4 14%
Economics, Econometrics and Finance 3 10%
Nursing and Health Professions 3 10%
Chemistry 2 7%
Business, Management and Accounting 1 3%
Other 6 21%
Unknown 10 34%

Attention Score in Context

This research output has an Altmetric Attention Score of 100. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 September 2022.
All research outputs
#337,068
of 22,132,418 outputs
Outputs from Cancer Epidemiology, Biomarkers & Prevention
#134
of 4,471 outputs
Outputs of similar age
#7,840
of 297,082 outputs
Outputs of similar age from Cancer Epidemiology, Biomarkers & Prevention
#1
of 48 outputs
Altmetric has tracked 22,132,418 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,471 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.3. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 297,082 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.